You are here:
Project
We have developed a CMOS biochip with which the prostate-specific antigen can be quantitatively detected. The chip achieves the specifications required for clinical PSA tests according to Rili-BÄK for early cancer detection.
Research
Imprint/Disclaimer
Privacy statement
Search
Home
Lead applications
Career
Social Media
Services for research and development
About us
References
News
Media library
